Bioactivity:

FosravuconazoleL-lysine ethanolate is a broad-spectrum antifungal agent. In Japan, it is approved for the treatment of onychomycosis, a fungal infection of the nail. It is a prodrug that is converted into ravuconazole.

CAS nr:

914361-45-8

Purity:

98%

Molecular Weight:

739,7

SMILES:

N#CC1=CC=C(C2=CSC([C@H](C)[C@@](OCOP(O)(O)=O)(C3=CC=C(F)C=C3F)CN4N=CN=C4)=N2)C=C1.CCO.N[C@H](C(O)=O)CCCCN

Formula:

C31H40F2N7O8PS

Pathway:

Microbiology/Virology,Others,Microbiology/Virology

Target:

Antifungal,Others,Parasite